Dual targeting approach improves immunotherapy response in glioblastoma

Researchers from The University of Texas MD Anderson Cancer Center have found that simultaneously blocking two key “don’t eat me signals” found in cancer cells heightens the immune response and sensitizes tumors to immunotherapy in models of glioblastoma (GBM), highlighting a promising strategy.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup